Literature DB >> 35663712

Accessory Spleen Masquerading as an Intrapancreatic Tumor: A Case Report.

Harrison C Smith1, Nandita Kakar1, Anthony M Shadid2.   

Abstract

The finding of splenic tissue within the pancreas, also known as splenosis or intrapancreatic accessory spleen (IPAS), is a relatively uncommon condition that presents as an intrapancreatic mass. The discovery of an intrapancreatic mass often prompts a thorough diagnostic workup for a primary pancreatic malignancy, often exposing patients to unnecessary risks associated with invasive testing and even surgery. The benign, asymptomatic nature of this finding places emphasis on utilizing non-invasive techniques for confirmation of the diagnosis, reducing risks of morbidity and mortality in this patient population. Contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) will display near-identical signal intensities (SI) between the spleen and the intrapancreatic mass, as well as identical contrast-enhancement patterns. Nuclear medicine evaluation with Tc-99m heat-damaged red blood cells (HDRBCs) is often used as a confirmatory test and allows for differentiation from malignancies.
Copyright © 2022, Smith et al.

Entities:  

Keywords:  abdominal pain; accessory spleen; ectopic spleen; nuclear medicine imaging; pancreatic tumor; splenosis

Year:  2022        PMID: 35663712      PMCID: PMC9159715          DOI: 10.7759/cureus.24677

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  3 in total

1.  CT features of the accessory spleen.

Authors:  Koenraad J Mortelé; Bart Mortelé; Stuart G Silverman
Journal:  AJR Am J Roentgenol       Date:  2004-12       Impact factor: 3.959

2.  Radiologic imaging of splenic anomalies.

Authors:  W J Dodds; A J Taylor; S J Erickson; E T Stewart; T L Lawson
Journal:  AJR Am J Roentgenol       Date:  1990-10       Impact factor: 3.959

3.  Intrapancreatic accessory spleen: Evaluation with CT and MRI.

Authors:  Qianjiang Ding; Zhihao Ren; Jianhua Wang; Xiaolong Ma; Jian Zhang; Gaofeng Sun; Changjing Zuo; Hao Gu; Hui Jiang
Journal:  Exp Ther Med       Date:  2018-08-17       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.